SciELO - Scientific Electronic Library Online

vol.78 issue2Cardiac Myxomas: Clinical Presentation, Surgical Outcomes and Long-term PrognosisPermanent Para-Hisian Pacing: Indications and Follow-Up author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO


Revista argentina de cardiología

On-line version ISSN 1850-3748


ZYLBERMAN, Marcelo et al. Usefulness of Intrapericardial Cisplatin for the Management of Malignant Pericardial Effusion. Rev. argent. cardiol. [online]. 2010, vol.78, n.2, pp.114-117. ISSN 1850-3748.

The recurrence rate of malignant pericardial effusion after pericardiocentesis is 62%. For this reason, intrapericardial instillation of therapeutic agents is performed after pericardial evacuation to improve the treatment. Cisplatin has proved to be a useful and safe agent. Objective To present our experience with intrapericardial instillation of cisplatin for the management of malignant pericardial disease. Material and Methods We included patients admitted to the Instituto Alexander Fleming between January 2005 and May 2009 with cardiac tamponade or severe pericardial effusion treated with pericardial drainage and instillation of cisplatin (10 mg in 20 ml of physiological solution for 5 days). Malignant pericardial effusion had to be confirmed by cytological examination or by echocardiographic evidence of malignant disease involving the pericardial space. Low treatment expectation was another requirement for inclusion. Results A total of 9 patients (6 men and 3 women) were included; mean age was 60 years (51-69). The primary tumors were lung cancer (n=4); breast cancer (n=1); bladder cancer (n=1); esophageal cancer (n=1), and prostate cancer (n=1). The cytological examination was positive in 6 cases. The catheter was removed after 7 days. Three patients presented adverse events: pain, fever and atrial fibrillation. One patient had a recurrence one month later. Eight patients died [mean time to death: 50 days (7-83)] and one is alive. Conclusion Intrapericardial instillation of cisplatin is a feasible and welltolerated procedure. The incidence of recurrences is low.

Keywords : Cisplatin; Chemotherapy; Pericardium; Metastases.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License